Granted Patent
B2
US 9,855,237 · App. 14/704,329 · Granted Jan 2, 2018
Methods of treating mixed dyslipidemia
Inventors:
Ian Osterloh (Kent, GB); Pierre Wicker (Mystic, CT); Rene Braeckman (Richboro, PA); Paresh Soni (Mystic, CT); Mehar Manku (Birminham, GB)
Assignee:
Amarin Pharmaceuticals Ireland Limited
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
Claims (3)
1. A method of treating hypertriglyceridemia in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising eicosapentaenoic acid (EPA) or a derivative of EPA, docosahexaenoic acid (DHA) or a derivative of DHA, and at least one surfactant.
2. The method of claim 1 wherein the pharmaceutical composition is administered to the subject in 1 to about 10 dosage units per day.
3. The method of claim 2 wherein the dosage units comprise capsules.
Assignments (3)
RELEASE OF SECURITY INTEREST
Recorded Nov 19, 2020
From: CPPIB CREDIT EUROPE S.À R.L.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054484/0552 →
SECURITY INTEREST
Recorded Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 11, 2016
From: OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE; SONI, PARESH; MANKU, MEHAR
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 039408/0041 →